Protext Mobility Inc
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida.
Protext Mobility Inc (TXTM) - Net Assets
Latest net assets as of March 2024: $14.36 Million USD
Based on the latest financial reports, Protext Mobility Inc (TXTM) has net assets worth $14.36 Million USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($15.00 Million) and total liabilities ($645.25K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $14.36 Million |
| % of Total Assets | 95.7% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 289.3 |
Protext Mobility Inc - Net Assets Trend (2002–2023)
This chart illustrates how Protext Mobility Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Protext Mobility Inc (2002–2023)
The table below shows the annual net assets of Protext Mobility Inc from 2002 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $14.38 Million | -0.38% |
| 2022-12-31 | $14.43 Million | +1343.33% |
| 2021-12-31 | $-1.16 Million | +29.46% |
| 2020-12-31 | $-1.65 Million | -47.00% |
| 2019-12-31 | $-1.12 Million | -416.10% |
| 2018-12-31 | $354.10K | -48.88% |
| 2017-12-31 | $692.73K | +7.40% |
| 2016-12-31 | $645.00K | -31.04% |
| 2015-12-31 | $935.30K | +116.41% |
| 2013-12-31 | $-5.70 Million | -27.89% |
| 2012-12-31 | $-4.46 Million | -66.49% |
| 2011-12-31 | $-2.68 Million | -49.87% |
| 2010-12-31 | $-1.79 Million | +38.32% |
| 2009-12-31 | $-2.90 Million | +20.18% |
| 2008-12-31 | $-3.63 Million | -8.18% |
| 2007-12-31 | $-3.35 Million | -131.22% |
| 2006-12-31 | $-1.45 Million | -826.39% |
| 2005-12-31 | $199.65K | -87.92% |
| 2004-12-31 | $1.65 Million | +4807.50% |
| 2003-12-31 | $-35.12K | +94.72% |
| 2002-12-31 | $-665.27K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Protext Mobility Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 258487400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $87.91K | 0.61% |
| Other Comprehensive Income | $-87.91K | -0.61% |
| Other Components | $17.86 Million | 124.22% |
| Total Equity | $14.38 Million | 100.00% |
Protext Mobility Inc Competitors by Market Cap
The table below lists competitors of Protext Mobility Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Carroll Shelby International Inc
PINK:CSBI
|
$8.71 |
|
METADVERTISE EO-10
F:MAV
|
$8.74 |
|
Consumer Automotive Finance Inc
PINK:CAFI
|
$8.76 |
|
Bliss-Tel PLC
BK:BLISS
|
$8.77 |
|
XTRA Bitcoin Inc
PINK:CBTC
|
$8.63 |
|
Armm Inc
PINK:ARMM
|
$8.29 |
|
Diguang Intl Dev Co
PINK:DGNG
|
$8.17 |
|
Swift Foods Inc
PSE:SFI
|
$8.14 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Protext Mobility Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 14,430,293 to 14,376,021, a change of -54,272 (-0.4%).
- Net loss of 54,272 reduced equity.
- Other comprehensive income decreased equity by 4,186.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-54.27K | -0.38% |
| Other Comprehensive Income | $-4.19K | -0.03% |
| Other Changes | $4.19K | +0.03% |
| Total Change | $- | -0.38% |
Book Value vs Market Value Analysis
This analysis compares Protext Mobility Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.55x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $-35.28 | $0.00 | x |
| 2003-12-31 | $-1.60 | $0.00 | x |
| 2004-12-31 | $49.35 | $0.00 | x |
| 2005-12-31 | $5.00 | $0.00 | x |
| 2006-12-31 | $-30.83 | $0.00 | x |
| 2007-12-31 | $-68.43 | $0.00 | x |
| 2008-12-31 | $-44.53 | $0.00 | x |
| 2009-12-31 | $-30.45 | $0.00 | x |
| 2010-12-31 | $-12.84 | $0.00 | x |
| 2011-12-31 | $-14.45 | $0.00 | x |
| 2012-12-31 | $-15.09 | $0.00 | x |
| 2013-12-31 | $-6.70 | $0.00 | x |
| 2016-12-31 | $0.00 | $0.00 | x |
| 2017-12-31 | $0.00 | $0.00 | x |
| 2018-12-31 | $0.00 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Protext Mobility Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.04x
- Recent ROE (-0.38%) is above the historical average (-107.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | -13518.35% | 0.01x | 0.00x | $-528.15K |
| 2003 | 0.00% | -23451.12% | 0.01x | 0.00x | $-1.06 Million |
| 2004 | -80.94% | -200936.19% | 0.00x | 1.36x | $-1.50 Million |
| 2005 | -1893.48% | -219.41% | 0.81x | 10.71x | $-3.80 Million |
| 2006 | 0.00% | -1237.59% | 0.13x | 0.00x | $-3.81 Million |
| 2007 | 0.00% | -7407.46% | 0.14x | 0.00x | $-5.93 Million |
| 2008 | 0.00% | -5558.50% | 0.31x | 0.00x | $-4.83 Million |
| 2009 | 0.00% | -14257.70% | 0.07x | 0.00x | $-4.19 Million |
| 2010 | 0.00% | -18406.60% | 0.10x | 0.00x | $-5.50 Million |
| 2011 | 0.00% | -13968.64% | 0.12x | 0.00x | $-3.32 Million |
| 2012 | 0.00% | -20403.90% | 3.49x | 0.00x | $-1.72 Million |
| 2013 | 0.00% | -225447.51% | 0.14x | 0.00x | $-877.51K |
| 2015 | -26.50% | 0.00% | 0.00x | 2.71x | $-341.43K |
| 2016 | -45.02% | 0.00% | 0.00x | 3.93x | $-354.90K |
| 2017 | -79.19% | 0.00% | 0.00x | 3.76x | $-617.88K |
| 2018 | -144.91% | 0.00% | 0.00x | 7.35x | $-548.54K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.39 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-341.50K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-26.23K |
| 2022 | 3.64% | 0.00% | 0.00x | 1.04x | $-917.88K |
| 2023 | -0.38% | 0.00% | 0.00x | 1.04x | $-1.49 Million |
Industry Comparison
This section compares Protext Mobility Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Protext Mobility Inc (TXTM) | $14.36 Million | 0.00% | 0.04x | $8.66 |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |